Document Detail

Chronic mountain sickness and the heart.
MedLine Citation:
PMID:  20417348     Owner:  NLM     Status:  MEDLINE    
Chronic Mountain Sickness (CMS) is an important high-altitude (HA) pathology in most mountainous regions of the world. Although its most characteristic sign is excessive erytrocytosis (EE), in the more severe stages of the disease, high-altitude pulmonary hypertension (HAPH), with remodeling of pulmonary arterioles and right ventricular enlargement is commonly found. The degree of ventricular hypertrophy depends on the vasoconstrictor pulmonary response, the intensity of vascular resistance and the level of altitude, and therefore on the degree of hypoxemia. This chapter briefly summarizes the existing data regarding the clinical and pathophysiological features of the cardiopulmonary system in CMS, with emphasis in findings from research in the Andes. The literature shows variability in cardiac output values in CMS, which might be related to the degree of EE. Recent findings have shown that cardiac output (l/min) is lower in CMS when compared with sea-level (SL) dwellers. Mean pulmonary acceleration time (ms) is significantly lower in CMS subjects than in SL and HA natives, and pulmonary vascular resistance index (Wood units) is higher in CMS and HA natives when compared with SL dwellers. Systemic blood pressure has similar values in CMS patients and healthy HA natives, but some differences arise in its control mechanisms. Although CMS individuals have a less effective vasoconstrictor reflex, their tolerance to orthostatic stress is similar to that of healthy HA natives which might be explained in terms of the larger blood volume present in CMS subjects. At present research is directed to design strategies on pharmacological intervention for CMS treatment. Recently, a clinical trial with acetazolamide, in patients with CMS has proven to be effective in increasing mean pulmonary acceleration time and decreasing pulmonary vascular resistance index, which might be indirectly due the reduction of hematocrit.
Fabiola León-Velarde; Francisco C Villafuerte; Jean-Paul Richalet
Related Documents :
1201578 - Pulmonary vasoconstriction produced by protamine and protamine-heparin complex in the i...
20195178 - Glossopharyngeal insufflation and pulmonary hemodynamics in elite breath hold divers.
1926148 - Effects of indomethacin in utero on the pulmonary vasculature of the newborn lambs.
3527468 - Early and late hemodynamic consequences of group b beta streptococcal sepsis in piglets...
2143478 - Effect of an angiotensin-converting enzyme inhibitor on blood pressure and erythropoies...
8349208 - Distal blood pressure as a predictor for the level of amputation in diabetic patients w...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Progress in cardiovascular diseases     Volume:  52     ISSN:  1873-1740     ISO Abbreviation:  Prog Cardiovasc Dis     Publication Date:    2010 May-Jun
Date Detail:
Created Date:  2010-04-26     Completed Date:  2010-05-13     Revised Date:  2013-05-02    
Medline Journal Info:
Nlm Unique ID:  0376442     Medline TA:  Prog Cardiovasc Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  540-9     Citation Subset:  AIM; IM    
Departamento de Ciencias Biológicas y Fisiológicas, Facultad de Ciencias y Filosofia, Universidad Peruana Cayetano Heredia, Lima 31, Perú. <>
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Altitude Sickness / blood,  drug therapy,  physiopathology*
Anoxia / physiopathology*
Blood Pressure
Cardiac Output*
Cardiovascular System / physiopathology*
Chemoreceptor Cells*
Chronic Disease
Clinical Trials as Topic
Hypertension, Pulmonary / physiopathology*
Hypertrophy, Right Ventricular / physiopathology
Polycythemia / physiopathology
Pulmonary Artery / physiopathology
Randomized Controlled Trials as Topic
Respiratory System / physiopathology*
Vascular Resistance

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Circulatory adaptation to long-term high altitude exposure in Aymaras and Caucasians.
Next Document:  Controlled evaluation of injury in an international Safe Community: Kashmar, Iran.